Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

851
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
851
Diabetic Nephropathy01:28

Diabetic Nephropathy

28
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
28
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.7K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.7K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Bone Disorders01:29

Bone Disorders

8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next-Generation Sequencing in Differentiated Thyroid Cancer Patients Treated with Lenvatinib: Results and Challenges in Real-Life Practice.

Current oncology (Toronto, Ont.)·2026
Same author

Consensus on acromegaly complications: an update.

Pituitary·2026
Same author

Gender differences in long-term complications of chronic hypoparathyroidism: a systematic review.

Journal of endocrinological investigation·2026
Same author

Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Clinical features of Italian adult individuals with X-linked hypophosphatemia: a multicenter retrospective study.

Endocrine connections·2026
Same author

Cardiometabolic Burden in Bilateral Macronodular Adrenal Disease With Primary Aldosteronism.

Hypertension (Dallas, Tex. : 1979)·2026

Related Experiment Video

Updated: Apr 28, 2026

Assessing Collagen and Elastin Pressure-dependent Microarchitectures in Live, Human Resistance Arteries by Label-free Fluorescence Microscopy
09:58

Assessing Collagen and Elastin Pressure-dependent Microarchitectures in Live, Human Resistance Arteries by Label-free Fluorescence Microscopy

Published on: April 9, 2018

9.6K

Bone microarchitectural degradation in hypertensive patients: a population-based study.

Fabio Bioletto1, Martina Bollati2, Marco Barale3

  • 1Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy. fabio.bioletto@unito.it.

Archives of Osteoporosis
|April 27, 2026
PubMed
Summary

Hypertension is linked to poorer bone microarchitecture, not lower bone density. This bone quality degradation may explain increased fracture risk in hypertensive individuals.

Keywords:
Anti-hypertensive medicationsBone microarchitectureBone qualityHypertensionTrabecular bone score

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

9.9K
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

2.6K

Related Experiment Videos

Last Updated: Apr 28, 2026

Assessing Collagen and Elastin Pressure-dependent Microarchitectures in Live, Human Resistance Arteries by Label-free Fluorescence Microscopy
09:58

Assessing Collagen and Elastin Pressure-dependent Microarchitectures in Live, Human Resistance Arteries by Label-free Fluorescence Microscopy

Published on: April 9, 2018

9.6K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

9.9K
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

2.6K

Area of Science:

  • Bone biology and osteoporosis research.
  • Cardiovascular health and its systemic effects.

Background:

  • Hypertension is a known risk factor for fractures, but its impact on bone mineral density (BMD) is debated.
  • Limited data exist on how hypertension affects bone microarchitectural quality.
  • The effects of antihypertensive drugs on bone quality are not well understood.

Purpose of the Study:

  • To investigate if hypertensive patients exhibit altered bone microarchitecture using trabecular bone score (TBS).
  • To explore the relationship between antihypertensive medications and TBS as a secondary objective.

Main Methods:

  • Utilized data from 7053 subjects from the National Health and Nutrition Examination Survey (NHANES) 2005-2008.
  • Calculated TBS from lumbar spine dual-energy X-ray absorptiometry (DXA) images.
  • Performed regression analyses to assess associations between hypertension, medications, and bone outcomes, adjusting for confounders.

Main Results:

  • Hypertension was independently associated with significantly lower TBS, indicating degraded bone microarchitecture.
  • No significant association was found between hypertension and BMD at the lumbar spine, total hip, or femoral neck.
  • No specific class of antihypertensive medications showed a significant association with TBS.

Conclusions:

  • Hypertension is associated with impaired bone microarchitecture but not reduced bone mass.
  • No significant link was identified between antihypertensive drug classes and TBS.
  • Observed associations between certain antihypertensive medications and BMD align with prior research.